NEW YORK, April 19 (GenomeWeb News) - Compugen will study biological interaction networks for Novartis by using a platform for analyzing microarray and other data it intends to develop, the Tel Aviv, Israel-based company said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.
After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.
Canada begins its search for a chief government science advisor, Nature News reports.
A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.